Pakistan Synthetics Past Earnings Performance
Past criteria checks 1/6
Pakistan Synthetics has been growing earnings at an average annual rate of 26.5%, while the Chemicals industry saw earnings growing at 15.5% annually. Revenues have been growing at an average rate of 18.9% per year. Pakistan Synthetics's return on equity is 6.9%, and it has net margins of 2.2%.
Key information
26.5%
Earnings growth rate
27.2%
EPS growth rate
| Chemicals Industry Growth | 19.3% |
| Revenue growth rate | 18.9% |
| Return on equity | 6.9% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pakistan Synthetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 13,680 | 302 | 427 | 0 |
| 30 Jun 24 | 13,800 | 348 | 438 | 0 |
| 31 Mar 24 | 13,523 | 484 | 497 | 0 |
| 31 Dec 23 | 14,067 | 603 | 511 | 0 |
| 30 Sep 23 | 14,346 | 664 | 532 | 0 |
| 30 Jun 23 | 14,425 | 798 | 496 | 0 |
| 31 Mar 23 | 14,611 | 882 | 474 | 0 |
| 31 Dec 22 | 13,106 | 833 | 421 | 0 |
| 30 Sep 22 | 13,313 | 949 | 414 | 0 |
| 30 Jun 22 | 12,311 | 986 | 370 | 0 |
| 31 Mar 22 | 10,927 | 1,199 | 251 | 0 |
| 31 Dec 21 | 9,898 | 1,205 | 234 | 0 |
| 30 Sep 21 | 8,358 | 972 | 198 | 0 |
| 30 Jun 21 | 7,251 | 748 | 191 | 0 |
| 31 Mar 21 | 6,612 | 166 | 225 | 0 |
| 31 Dec 20 | 6,281 | -11 | 195 | 0 |
| 30 Sep 20 | 6,483 | -41 | 192 | 0 |
| 30 Jun 20 | 6,587 | -99 | 176 | 0 |
| 31 Mar 20 | 6,769 | -48 | 170 | 0 |
| 31 Dec 19 | 6,879 | -15 | 155 | 0 |
| 30 Sep 19 | 7,233 | -135 | 155 | 0 |
| 30 Jun 19 | 7,025 | -124 | 148 | 0 |
| 31 Mar 19 | 6,291 | 96 | 128 | 0 |
| 31 Dec 18 | 6,083 | 86 | 144 | 0 |
| 30 Sep 18 | 5,567 | 184 | 134 | 0 |
| 30 Jun 18 | 5,253 | 150 | 128 | 0 |
| 31 Mar 18 | 4,762 | 42 | 117 | 0 |
| 31 Dec 17 | 4,159 | 6 | 110 | 0 |
| 30 Sep 17 | 3,668 | 78 | 113 | 0 |
| 30 Jun 17 | 2,912 | 84 | 106 | 0 |
| 31 Mar 17 | 2,271 | 178 | 103 | 0 |
| 31 Dec 16 | 1,768 | 192 | 95 | 0 |
| 30 Sep 16 | 1,633 | 177 | 88 | 0 |
| 30 Jun 16 | 1,661 | 202 | 88 | 0 |
| 31 Mar 16 | 1,620 | 263 | 79 | 0 |
| 31 Dec 15 | 1,586 | 223 | 79 | 0 |
| 30 Sep 15 | 1,531 | 172 | 74 | 0 |
| 30 Jun 15 | 1,544 | 175 | 72 | 0 |
| 31 Mar 15 | -1,448 | 137 | 35 | 0 |
| 31 Dec 14 | -484 | 177 | 41 | 0 |
| 30 Sep 14 | 440 | 195 | 53 | 0 |
| 30 Jun 14 | 1,479 | 153 | 62 | 0 |
| 31 Mar 14 | 5,241 | 63 | 101 | 0 |
| 31 Dec 13 | 5,163 | 19 | 93 | 0 |
Quality Earnings: PSYL has a large one-off loss of PKR389.5M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: PSYL's current net profit margins (2.2%) are lower than last year (4.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PSYL has become profitable over the past 5 years, growing earnings by 26.5% per year.
Accelerating Growth: PSYL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PSYL had negative earnings growth (-54.5%) over the past year, making it difficult to compare to the Chemicals industry average (-11.2%).
Return on Equity
High ROE: PSYL's Return on Equity (6.9%) is considered low.